Pep-Therapy logo
VerifiedBiotechnology Research· Founded 2014

Pep-Therapy

PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.

7-day free trial · no credit card

HeadquartersParis, FranceEmployees12(1 to 10)Founded year2014Websitepep-therapy.comLinkedIn profileLinkedIn

Verified contacts

9

available on Kipplo

LinkedIn employees

12

1 to 10 range

Open roles

no listings

Distinct roles

9

indexed titles

Tech stack

0

tools in use

Monthly traffic

114

organic / mo

Sign up free to see all 9 verified contacts at Pep-Therapy

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

9 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Pep-Therapy

9 distinct titles indexed · top 9 shown.

  • 1- ()
  • 1board member
  • 1business development analyst
  • 1chef de projet r & d
  • 1communication specialist
  • 1designer
  • 1head of drug development
  • 1head of research
  • 1head of strategy and development

Sign up to unlock all 9 contacts at Pep-Therapy

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 9 verified contacts at Pep-Therapy

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Pep-Therapy | Kipplo Discover